Healthcare provider profile · identity verified

David Chadwick Weston, M.D.

Family Practice · SHALLOTTE, NC · NPI 1639167455

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	466	114
Levothyroxine Sodium	Levothyroxine Sodium	409	96
Amlodipine Besylate	Amlodipine Besylate	367	100
Lisinopril	Lisinopril	289	77
Rosuvastatin Calcium	Rosuvastatin Calcium	274	76
Metoprolol Succinate	Metoprolol Succinate	249	61
Omeprazole	Omeprazole	232	65
Losartan Potassium	Losartan Potassium	231	70
Pantoprazole Sodium	Pantoprazole Sodium	220	64
Hydrochlorothiazide	Hydrochlorothiazide	214	57
Gabapentin	Gabapentin	199	48
Metformin Hcl	Metformin Hcl	182	50
Meloxicam	Meloxicam	144	39
Metformin Hcl Er	Metformin Hcl	140	39
Allopurinol	Allopurinol	131	32
Trazodone Hcl	Trazodone Hcl	131	24
Sertraline Hcl	Sertraline Hcl	127	22
Simvastatin	Simvastatin	123	35
Tramadol Hcl	Tramadol Hcl	119	22
Metoprolol Tartrate	Metoprolol Tartrate	117	31
Tamsulosin Hcl	Tamsulosin Hcl	98	30
Albuterol Sulfate Hfa	Albuterol Sulfate	96	28
Montelukast Sodium	Montelukast Sodium	92	25
Hydroxyzine Hcl	Hydroxyzine Hcl	91	22
Pravastatin Sodium	Pravastatin Sodium	89	24
Escitalopram Oxalate	Escitalopram Oxalate	87	20
Glimepiride	Glimepiride	86	23
Potassium Chloride	Potassium Chloride	86	19
Duloxetine Hcl	Duloxetine Hcl	81	14
Pregabalin	Pregabalin	80	21
Fluticasone Propionate	Fluticasone Propionate	78	33
Furosemide	Furosemide	76	23
Venlafaxine Hcl Er	Venlafaxine Hcl	75	14
Zolpidem Tartrate	Zolpidem Tartrate	72	17
Doxepin Hcl	Doxepin Hcl	71	14
Eliquis	Apixaban	66	14
Symbicort	Budesonide/Formoterol Fumarate	64	12
Hydralazine Hcl	Hydralazine Hcl	63	13
Atenolol	Atenolol	62	15
Synthroid	Levothyroxine Sodium	62	19
Finasteride	Finasteride	59	18
Olmesartan Medoxomil	Olmesartan Medoxomil	59	15
Clopidogrel	Clopidogrel Bisulfate	58	20
Jardiance	Empagliflozin	48	12
Lovastatin	Lovastatin	48	12
Alendronate Sodium	Alendronate Sodium	47	suppressed
Azelastine Hcl	Azelastine Hcl	47	16
Carvedilol	Carvedilol	45	12
Diclofenac Sodium	Diclofenac Sodium	45	23
Ezetimibe	Ezetimibe	45	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	44	11
Prednisone	Prednisone	44	37
Januvia	Sitagliptin Phosphate	41	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	40	suppressed
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	36
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	17
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	12
Doxycycline Hyclate	Doxycycline Hyclate	35	31
Ibuprofen	Ibuprofen	34	suppressed
Buspirone Hcl	Buspirone Hcl	32	suppressed
Irbesartan	Irbesartan	32	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	31	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Clonazepam	Clonazepam	28	suppressed
Mounjaro	Tirzepatide	28	suppressed
Testosterone Cypionate	Testosterone Cypionate	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	20
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Primidone	Primidone	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Celecoxib	Celecoxib	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Eszopiclone	Eszopiclone	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Ibandronate Sodium	Ibandronate Sodium	20	suppressed
Labetalol Hcl	Labetalol Hcl	20	suppressed
Glipizide Er	Glipizide	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Glipizide	Glipizide	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Topiramate	Topiramate	15	suppressed
Torsemide	Torsemide	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Ozempic	Semaglutide	13	suppressed
Testosterone	Testosterone	13	suppressed
Valsartan	Valsartan	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Baclofen	Baclofen	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Roflumilast	Roflumilast	12	suppressed
Anastrozole	Anastrozole	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Famotidine	Famotidine	11	suppressed
Indapamide	Indapamide	11	suppressed
Invokana	Canagliflozin	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Naproxen	Naproxen	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error